title: [The Medical Products Agency suggests improved drug safety follow-ups. New grasps of better knowledge and adverse effects reporting].
authors.affiliation: gunilla.sjolin-forsberg@mpa.se
authors.forename: Gunilla
authors.initials: G
authors.lastname: Sjölin-Forsberg
authors.forename: Bengt
authors.initials: B
authors.lastname: Lindeskog
authors.forename: Kristina Magnusson
authors.initials: KM
authors.lastname: Lundqvist
authors.forename: Nils
authors.initials: N
authors.lastname: Feltelius
authors.forename: Gunnar
authors.initials: G
authors.lastname: Alvan
mesh_terms: D016907:Adverse Drug Reaction Reporting Systems / Q000592:standards; D064420:Drug-Related Side Effects and Adverse Reactions; D005060:Europe; D006801:Humans; D013548:Sweden